PMID: 9182473Jun 15, 1997Paper

Correction of excessive anticoagulation with low-dose oral vitamin K1

Annals of Internal Medicine
R T WeibertS I Rapaport

Abstract

Despite earlier acceptance of oral vitamin K1 (phytonadione) for the treatment of excessive anticoagulation, some recent guidelines do not recommend its use. To reevaluate the efficacy of oral vitamin K1 in correcting excessive anticoagulation. Case series. Anticoagulation clinics at two university medical centers. 81 outpatients who had an international normalized ratio (INR) greater than 5.0 but did not have significant bleeding. Withholding 1 or 2 doses of warfarin, administering 2.5 mg of oral vitamin K1, measuring the INR after 24 to 48 hours, and adjusting the warfarin dose. INRs were obtained from a portable capillary fingerstick monitor or from an automated photooptical coagulometer. In 68 of 71 patients (96%), oral vitamin K1 lowered the INR from between 5.0 and 10.0 to less than 5.0 without inducing resistance to further anticoagulation. Withholding 1 or 2 doses of warfarin and administering 2.5 mg of oral vitamin K1 is a reliable, safe, and inexpensive way to rapidly correct excessive anticoagulation (INR > 5.0) in patients who do not have serious bleeding episodes and have an INR of less than 10.0.

Citations

May 8, 2000·Journal of Clinical Laboratory Analysis·R S RileyL M Fisher
May 10, 2008·Journal of Thrombosis and Thrombolysis·Emily B DevineAnn K Wittkowsky
Nov 13, 2008·Internal and Emergency Medicine·Marcel Levi
Mar 1, 2003·The Journal of Emergency Medicine·Christina Wjasow, Robert McNamara
Feb 19, 2002·British Journal of Haematology·Henry G WatsonMike Makris
Jul 19, 2002·Seminars in Hematology·S Jean Chai, B Gail Macik
Mar 25, 2008·Therapeutics and Clinical Risk Management·Gregory William Roberts, Robert Adams
Feb 18, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Thomas Hanslik, Jacques Prinseau
Mar 3, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Sarah E WilsonMark A Crowther
Oct 29, 2004·Journal of Clinical Pathology·J P Hanley
Aug 9, 2003·Expert Opinion on Drug Safety·Rebecca J Beyth
Oct 7, 2015·Neurocritical Care·Gretchen M BrophyLori Shutter
Aug 12, 2009·The Medical Clinics of North America·Paul J GrantAmir K Jaffer
May 9, 2003·Clinics in Geriatric Medicine·Andrew R Berman, Julia H Arnsten
Mar 29, 2001·Clinics in Geriatric Medicine·A R Berman
Mar 15, 2008·Critical Pathways in Cardiology·Eli V GelfandSamuel Z Goldhaber
Dec 22, 1999·Pharmacotherapy·C T TaylorM A Stephens
Sep 1, 2001·British Journal of Haematology·M Makris, H G Watson
Jul 31, 2001·Emergency Medicine·J CruickshankD Eddey
Dec 10, 2003·Circulation·Samuel Z Goldhaber, C Gregory Elliott
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·F DentaliM Crowther
May 12, 2005·Progress in Cardiovascular Nursing·Steven R Kayser
Aug 12, 2000·Drugs & Aging·J L Sebastian, D D Tresch
Dec 22, 2007·Expert Review of Cardiovascular Therapy·Katherine W Phillips, Jack Ansell
Oct 16, 2010·Transfusion·Maria TavaresJoseph Sweeney
Oct 14, 2014·Journal of Thrombosis and Haemostasis : JTH·N van ReinF J M van der Meer
Mar 7, 2001·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·C G FondevilaM D Pinto
Sep 16, 2017·Neurocritical Care·Gretchen M Brophy, Theresa Human
Jun 29, 2012·Transfusion·Robert MeehanJoseph Sweeney

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.